RecruitingNot ApplicableNCT06643286

Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma

Personalised Survivorship Care for Patients With Melanoma: A Multicenter Randomised Controlled Trial of the Survivorship Care Plan App

Sponsor

Erasmus Medical Center

Enrollment

180 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Survivorship Melanoma (Skin)Melanoma, Stage II, Stage I Melanoma Stage

Summary

A multicentre randomised controlled trial (RCT) will be conducted to evaluate the effectiveness of the digital personalised Melanoma Survivorship Care Plan (SCP) app. A total of hundred-eighty melanoma patients (stage I and II) will be randomised to receive either the SCP Melanoma app or usual care. The app provides survivors with personalized healthcare information on diagnosis, treatment and follow-up and supportive care, tailored to their melanoma stage and phase and information needs.Through questionnaires, medical file records, patient-reported outcomes and use of medical care will be evaluated. In addition, log-data, questionnaires and interviews will be used to evaluate the process of the uptake and implementation of the digital SCP.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a personalized app-based survivorship care plan to support people recently diagnosed with early-stage skin melanoma as they transition through and beyond their treatment. **You may be eligible if...** - You are 18 years or older - You have received a primary diagnosis of cutaneous (skin) melanoma at stage I or II within the past 0 to 4 months - You understand Dutch **You may NOT be eligible if...** - You have stage III melanoma that cannot be surgically removed - You are currently receiving neoadjuvant (pre-surgery) treatment - You have stage IV (metastatic) melanoma - You do not have a sufficient command of the Dutch language Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDigizorg Melanoma app

The Digizorg Melanoma app is a digital survivorship care plan, in which ellaborated information regarding diagnosis, treatment and follow-up and supportive care, adjusted to one's personal preferences and disease characteristics, is offered in the form of a mobile application.